SUMMARY
In a previous study it was noted that patients who had an anaphylactoid reaction to anaesthetic drugs had a higher incidence of past reactions than the general population. I Hurwitz showed in a study of adverse drug reactions to drugs in hospital that of 17 patients with hypersensitivity reactions, four had had previous reactions. In three of these the second reaction was to the same drug or a structurally similar drug. 2 In 13 of 116 patients with anaphylactoid reactions and one patient with a delayed hypersensitivity reaction to anaesthesia, there was a history of a previous reaction to anaesthesia.
This paper describes the reactions in these patients and discusses how second reactions may be prevented.
CASE REPORTS
The reactions are summarised in Table 1 In addition Althesin and propanidid, which share a common vehicle, may not be safe alternatives to each other. 3 In Case 2 the anaesthetist chose a less safe drug on the basis of a spurious history of a reaction to a safe drug. iii) Failure of adequate communication. In Case 12 the patient was informed of some "minor trouble" with the first anaesthetic of which she did not inform the second anaesthetist. Retrieval of the first anaesthetic records showed an identical reaction after propanidid. In Case 14 the patient stated that her mother had told her she was allergic to thiopentone, and it was felt that this was insufficient evidence to proceed without further investigation. She had a strong allergic history and had received Althesin within three months, which, it was felt, placed her at risk from this alternative induction agent. She was tested intradermally and given test doses prior to anaesthesia uneventfully, but developed a delayed hypersensitivity reaction which intradermal testing will not detect. Had this patient had written documentation of the previous reaction safe anaesthesia could have been administered without risk. In two patients (Cases 7 and 9) no cause has been ascertained. In Case 6 the collapse was of short duration and may have been due to overdose. Case 9 reacted to two drugs of totally different structure and had negative intradermal tests. Reactions to drugs of different structure in a single patient may occur due to activation of the alternate complementary pathway. 5, 6 These reactions are unlikely to be detected by intradermal testing.
In Case 8 and 9 the first reaction was generalised erythema and the second reaction generalised erythema plus systemic manifestations. While rashes occur commonly during anaesthesia and have no prognostic significance, generalised erythema may be a harbinger of future sensitivity. Intradermal testing is unlikely to determine the drug responsible 3 and generalised erythema is not always followed by a reaction at subsequent administration.
After an anaphylactoid reaction to anaesthetic drugs the following steps should be taken: 1. The causative drug identified if possible.
Intradermal testing should be carried out unless the drug is the sole agent used. 2. The nature of the reaction and the drug responsible for the reaction should be told to the patient or the patient's parents and the patient encouraged to wear a Medic Alert or other identifying bracelet or medallion. The patient should be given a note describing the drugs used, the reaction which occurred, and the evidence for attributing the reaction to a particular drug. Details of subsequent uneventful anaesthesia should be added to this note.
A second group of patients should also be considered. Patients may present on the night before operation with a history of allergy to anaesthesia, or to a specific drug without any evidence to support this. Cases 1 to 4 illustrate the consequences of accepting the patient's unsubstantiated history and Case 14 the hazards of disbelieving the history.
A rational approach to this problem is: 1. History a) Endeavour to determine the nature of the reaction. Postoperative vomiting, prolonged neuromuscular block, muscle pains and malignant hyperpyrexia may all be described by patients as allergic. b) If no information is available from records of patient, assume patient is allergic to drug stated but possibly allergic to alternatives.
Intradermal testing
This should be done and when positive the drug implicated should be avoided. 3 If all tests are negative, pretreatment should be considered. 8 
Pretreatment
Pretreatment with various drug combinations has been advocated. The evidence regarding pretreatment may be summarised as follows: Sutherland 9 has stated that pretreatment with corticosteroids, HI antihistamines and adrenaline has virtually eliminated reactions to antivenoms. Greenberger et al. lO had only one moderately severe reaction to contrast in 201 patients with a past history of a severe reaction after administering prednisone 5 mg six hourly, terminating one hour before the procedure, and diphenhydramine 50 mg intravenously one hour before the procedure. Lalli, however, showed a significant reduction in reactions to contrast with reassurance alone. ll Lorenz et al. showed that HI and H2 blockers in combination could prevent reactions to haemaccel 12 but the relevance of the study has been questioned. 13 In addition Lorenz et al. have shown that high dose methylprednisolone and antihistamines prevented an anaphylactoid reaction in an anaesthetist allergic to propanidid. 14 Disodium chromoglycate has been advocated l5 but there is no data to support its use. In summary, pretreatment with high dose steroids and antihistamines, with the possible addition of subcutaneous adrenaline, offers the best chance of protection.
Test dose
Where relaxant anaesthesia is necessary, history unavailable, and investigation not practicable or inconclusive, intravenous drugs should be administered cautiously. The use of small test doses has been shown to be ineffective and dangerous for contrast, Althesin, and antibiotics,16 but a cautious test dose of an alternative drug may be safe with local anaesthetics. 17 
Alternative techniques
Regional block, inhalation anaesthesia and use of low risk drugs (diazepam, fentanyl, phenoperidine) offers a safe alternative. The patient should be investigated subsequently to determine the nature of the previous reaction.
It is probably not possible to completely eliminate the occurrence of second anaphylactoid reactions to anaesthetic drugs but adequate investigation, communication and precautions should reduce the risk. 
